Insightful Analysis: Salarius Pharmaceuticals and Market Trends

Shares of Salarius Pharmaceuticals, Inc. SLRX surged in pre-market trading after reporting
fourth-quarter results.

Salarius Pharmaceuticals recorded a net loss of $0.9 million, or 22 cents
per share for the fourth quarter, which is notably narrower than the year-ago loss of $6.4 million, or
$2.83 per share, as stated by Benzinga Pro.

Salarius Pharmaceuticals shares surged by 31.4% to $0.8149 in pre-market
trading.

Here are some other notable stocks making moves in pre-market trading.

Standout Gainers

• Next.e.GO N.V. EGOX saw its shares rise by 85.8%
  to $0.0730 in pre-market trading after a decline of around 22% on Friday.
• MicroAlgo Inc. MLGO witnessed a 56.7% increase to
  $6.30 in pre-market trading following a minor 5% drop on Friday.
• Forge Global Holdings, Inc. FRGE experienced a 22.8% gain to
  $2.86 in pre-market trading after a 13% rise on Friday.
• Canopy Growth Corporation CGC surged by 19.5% to $9.17 in
  pre-market trading, driven by recent legislation in Germany legalizing cannabis possession and
  cultivation from April 1.
• Flora Growth Corp. FLGC rose by 17.7% to $1.86 in
  pre-market trading following a significant 34% surge on Friday.
• Cazoo Group Ltd CZOO climbed by 17.3% to $4.35
  in pre-market trading after a 21% decline on Friday.
• Biophytis S.A. BPTS saw a 17.1% increase to
  $0.4471 in pre-market trading, presenting its Phase 3 protocol of Ruvembri™ for Sarcopenia
  treatment at the ICFSR.
• Recon Technology, Ltd. RCON witnessed a 14.5% rise to
  $0.1570 in pre-market trading.
• Esperion Therapeutics, Inc. ESPR gained 12.7% to $2.58 in
  pre-market trading after the U.S. FDA approved expanded labels for NEXLETOL® and NEXLIZET® to
  prevent cardiac events in both primary and secondary prevention patients, regardless of statin
  use.

Notable Losers

• Sintx Technologies, Inc. SINT dropped by 29.7% to $0.0650
  in pre-market trading, following a 32% decline on Friday due to a public offering announcement.
• Invivyd, Inc. IVVD declined by 14.8% to $3.72
  in pre-market trading, after a 41% surge on Friday post FDA emergency use authorization for
  PEMGARDA in COVID-19 prophylaxis.
• Greenlane Holdings, Inc. GNLN fell by 10.8% to $0.52 in
  pre-market trading after an 11% increase on Friday.
• BYND Cannasoft Enterprises Inc. BCAN dropped by 10.8% to $2.24
  in pre-market trading, following a 31% dip on Friday.
• Mangoceuticals, Inc. MGRX tumbled by 9.7% to $0.1688
  in pre-market trading after a 5% decline on Friday.
• Australian Oilseeds Holdings Limited COOT fell by 8.5% to $2.27 in
  pre-market trading after a 22% drop on Friday.
• Ontrak, Inc. OTRK witnessed an 8.2% decline
  to $0.36 in pre-market trading after a 50% jump on Friday.
• Murano Global Investments Plc MRNO saw its shares fall by
  7.6% to $19.64 in pre-market trading due to volatility post business combination with HCM
  Acquisition Corp and Nasdaq debut.
• Laser Photonics Corporation LASE experienced a 6.5% decline
  to $1.73 in pre-market trading after a 9% dip on Friday, following a distribution agreement
  with ISL for laser solutions.
• OKYO Pharma Limited OKYO tumbled by 6.2% to $1.44
  post a 13% fall on Friday, following findings from a Phase 2 trial on OK-101 ophthalmic solution
  for dry eye disease.

 

Now Read This: Top 5 Consumer Stocks That May Crash This Month